Elanco executive receives equity grants, shares withheld

Elanco Animal Health executive Timothy J. Bettington reported multiple equity transactions on March 1, 2026.

Rhea-AI Filing Summary

Elanco Animal Health executive Timothy J. Bettington reported multiple equity transactions on March 1, 2026. He received an employee stock option grant for 19,350 options and several grants of common stock totaling 55,792 shares as awards. A separate transaction disposed of 18,098 common shares at $26.40 per share to cover tax withholding. The restricted stock units and stock options vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Bettington Timothy J

Role SEE REMARKS

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	19,350	$0.00	$0.00
Grant/Award	Common Stock	46,322	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	18,098	$26.40	$478K
Grant/Award	Common Stock	9,470	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 19,350 contracts (Direct); Common Stock — 147,956 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
2. F2. Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Timothy J. Bettington report at Elanco (ELAN)?

Timothy J. Bettington reported equity awards and related tax withholding at Elanco. He received 19,350 employee stock options and multiple grants of common stock, while 18,098 common shares were disposed of at $26.40 per share to satisfy tax obligations tied to these awards.

How many Elanco (ELAN) stock options were granted to Timothy J. Bettington?

He received an employee stock option grant covering 19,350 shares of Elanco common stock. These options are scheduled to vest in three equal tranches on March 1, 2027, March 1, 2028, and March 1, 2029, aligning with typical multi‑year executive incentive structures.

How many Elanco (ELAN) common shares were granted to Timothy J. Bettington?

Bettington received common stock awards totaling 55,792 shares on March 1, 2026. These include restricted stock units that vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, reflecting a long-term equity compensation package from Elanco Animal Health.

Why were 18,098 Elanco (ELAN) shares disposed of at $26.40?

The 18,098 Elanco common shares disposed of at $26.40 per share were used to pay tax liabilities related to equity awards. The transaction is coded as “F,” meaning shares were withheld or delivered specifically to satisfy exercise price or tax withholding obligations.

What is the vesting schedule for Timothy J. Bettington’s Elanco (ELAN) restricted stock units?

His restricted stock units vest in three equal installments over three years. One-third vests on March 1, 2027, another third on March 1, 2028, and the final portion on March 1, 2029, providing a staggered, time-based incentive structure for the executive.

What is the vesting schedule for Timothy J. Bettington’s Elanco (ELAN) stock options?

The granted stock options follow the same three-year vesting schedule. One-third of the options vest on March 1, 2027, another third on March 1, 2028, and the remaining third on March 1, 2029, encouraging longer-term alignment with Elanco’s performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:13 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bettington Timothy J

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		A		46,322	A	$0	156,584	D
Common Stock	03/01/2026		F		18,098	D	$26.4	138,486	D
Common Stock	03/01/2026		A		9,470(1)	A	$0	147,956	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$24.6	03/01/2026		A		19,350		(2)	03/01/2036	Common Stock	19,350	$0	19,350	D

Explanation of Responses:

1. Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

2. Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

Remarks:

Executive Vice President, Center of Strategic Growth

	/s/ Amy C. Seidel, as Attorney-in-Fact for Timothy J. Bettington	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.